{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:15:31Z","timestamp":1783296931127,"version":"3.54.6"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41440-026-02672-y","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:47:59Z","timestamp":1779173279000},"page":"2072-2085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic and body composition shifts after adrenalectomy in unilateral primary aldosteronism"],"prefix":"10.1038","volume":"49","author":[{"given":"Yuanyuan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riqiang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"2672_CR1","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, Williams TA. Diagnosis and treatment of primary aldosteronism. Lancet Diab Endocrinol. 2021;9:876\u201392.","journal-title":"Lancet Diab Endocrinol"},{"key":"2672_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"2672_CR3","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","volume":"157","author":"L Yip","year":"2022","unstructured":"Yip L, Duh QY, Wachtel H, Jimenez C, Sturgeon C, Lee C, et al. American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. JAMA Surg. 2022;157:870\u20137.","journal-title":"JAMA Surg"},{"key":"2672_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41574-020-0382-4","volume":"16","author":"MC Zennaro","year":"2020","unstructured":"Zennaro MC, Boulkroun S, Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol. 2020;16:578\u201389.","journal-title":"Nat Rev Endocrinol"},{"key":"2672_CR5","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41440-020-0468-3","volume":"43","author":"S Morimoto","year":"2020","unstructured":"Morimoto S, Ichihara A. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension. Hypertens Res. 2020;43:744\u201353.","journal-title":"Hypertens Res"},{"key":"2672_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","volume":"71","author":"GP Rossi","year":"2018","unstructured":"Rossi GP, Maiolino G, Flego A, Belfiore A, Bernini G, Fabris B, et al. Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term. Hypertension. 2018;71:585\u201391.","journal-title":"Hypertension"},{"key":"2672_CR7","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1210\/js.2019-00019","volume":"3","author":"YY Chen","year":"2019","unstructured":"Chen YY, Lin YH, Huang WC, Chueh E, Chen L, Yang SY, et al. Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism. J Endocr Soc. 2019;3:1110\u201326.","journal-title":"J Endocr Soc"},{"key":"2672_CR8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","volume":"3","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism. JAMA Cardiol. 2018;3:768\u201374.","journal-title":"JAMA Cardiol"},{"key":"2672_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41440-019-0244-4","volume":"42","author":"M Satoh","year":"2019","unstructured":"Satoh M, Maruhashi T, Yoshida Y, Shibata H. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism. Hypertens Res. 2019;42:817\u201324.","journal-title":"Hypertens Res"},{"key":"2672_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diab Endocrinol. 2018;6:51\u20139.","journal-title":"Lancet Diab Endocrinol"},{"key":"2672_CR11","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1097\/HJH.0000000000002070","volume":"37","author":"T Katabami","year":"2019","unstructured":"Katabami T, Fukuda H, Tsukiyama H, Tanaka Y, Takeda Y, Kurihara I, et al. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism. J Hypertens. 2019;37:1513\u201320.","journal-title":"J Hypertens"},{"key":"2672_CR12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.surg.2020.07.046","volume":"169","author":"O Picado","year":"2021","unstructured":"Picado O, Whitfield BW, Khan ZF, Jeraq M, Farr\u00e1 JC, Lew JI. Long-term outcome success after operative treatment for primary aldosteronism. Surgery. 2021;169:528\u201332.","journal-title":"Surgery"},{"key":"2672_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","volume":"74","author":"GP Rossi","year":"2019","unstructured":"Rossi GP, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, et al. Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling. Hypertension. 2019;74:800\u20138.","journal-title":"Hypertension"},{"key":"2672_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00268-019-05265-8","volume":"44","author":"F Sellgren","year":"2020","unstructured":"Sellgren F, Koman A, Nordenstr\u00f6m E, Hellman P, Hennings J, Muth A. Outcomes After Surgery for Unilateral Dominant Primary Aldosteronism in Sweden. World J Surg. 2020;44:561\u20139.","journal-title":"World J Surg"},{"key":"2672_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/jch.12916","volume":"18","author":"JL Benham","year":"2016","unstructured":"Benham JL, Eldoma M, Khokhar B, Roberts DJ, Rabi DM, Kline GA. Proportion of Patients With Hypertension Resolution Following Adrenalectomy for Primary Aldosteronism: A Systematic Review and Meta-Analysis. J Clin Hypertens. 2016;18:1205\u201312.","journal-title":"J Clin Hypertens"},{"key":"2672_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diab Endocrinol. 2017;5:689\u201399.","journal-title":"Lancet Diab Endocrinol"},{"key":"2672_CR17","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1210\/jc.2018-00059","volume":"103","author":"M Takeda","year":"2018","unstructured":"Takeda M, Yamamoto K, Akasaka H, Rakugi H, Naruse M, Takeda Y, et al. Clinical Characteristics and Postoperative Outcomes of Primary Aldosteronism in the Elderly. J Clin Endocrinol Metab. 2018;103:3620\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"2672_CR18","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","volume":"75","author":"GK Adler","year":"2020","unstructured":"Adler GK, Murray GR, Turcu AF, Nian H, Yu C, Solorzano CC, et al. Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans. Hypertension. 2020;75:1251\u20139.","journal-title":"Hypertension"},{"key":"2672_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.diabet.2019.10.002","volume":"46","author":"H Komada","year":"2020","unstructured":"Komada H, Hirota Y, So A, Nakamura T, Okuno Y, Fukuoka H, et al. Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma. Diab Metab. 2020;46:236\u201342.","journal-title":"Diab Metab"},{"key":"2672_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1507\/endocrj.EJ16-0500","volume":"64","author":"Y Tsurutani","year":"2017","unstructured":"Tsurutani Y, Sugisawa C, Ishida A, Inoue K, Saito J, Omura M, et al. Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism. Endocr J. 2017;64:339\u201346.","journal-title":"Endocr J"},{"key":"2672_CR21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3803\/EnM.2020.797","volume":"35","author":"YF Lin","year":"2020","unstructured":"Lin YF, Peng KY, Chang CH, Hu YH, Wu VC, Chung SD. Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism. Endocrinol Metab. 2020;35:838\u201346.","journal-title":"Endocrinol Metab"},{"key":"2672_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep15297","volume":"5","author":"CH Wu","year":"2015","unstructured":"Wu CH, Yang YW, Hung SC, Tsai YC, Hu YH, Lin YH, et al. Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone. Sci Rep. 2015;5:15297.","journal-title":"Sci Rep"},{"key":"2672_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/jch.70097","volume":"27","author":"E Nakano","year":"2025","unstructured":"Nakano E, Mukai K, Yamamoto K, Otsuki M, Fukuhara A, Shimomura I. Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the Treatment. J Clin Hypertens. 2025;27:e70097.","journal-title":"J Clin Hypertens"},{"key":"2672_CR24","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1210\/jc.2014-3551","volume":"100","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Zhang C, Wang W, Su T, Zhou W, Jiang L, et al. Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2015;100:1837\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"2672_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1467-789x.2000.00006.x","volume":"1","author":"A Tremblay","year":"2000","unstructured":"Tremblay A, Doucet E. Obesity: a disease or a biological adaptation? Obes Rev. 2000;1:27\u201335.","journal-title":"Obes Rev"},{"key":"2672_CR26","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1096\/fj.06-7970com","volume":"21","author":"M Caprio","year":"2007","unstructured":"Caprio M, F\u00e8ve B, Cla\u00ebs A, Viengchareun S, Lomb\u00e8s M, Zennaro MC. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. Faseb J. 2007;21:2185\u201394.","journal-title":"Faseb J"},{"key":"2672_CR27","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/cvr\/cvx097","volume":"113","author":"G Jia","year":"2017","unstructured":"Jia G, Aroor AR, Sowers JR. The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall. Cardiovasc Res. 2017;113:1055\u201363.","journal-title":"Cardiovasc Res"},{"key":"2672_CR28","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00125-012-2814-8","volume":"56","author":"P Luo","year":"2013","unstructured":"Luo P, Dematteo A, Wang Z, Zhu L, Wang A, Kim HS, et al. Aldosterone deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in mice. Diabetologia. 2013;56:901\u201310.","journal-title":"Diabetologia"},{"key":"2672_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1210\/en.2017-00651","volume":"159","author":"C Wu","year":"2018","unstructured":"Wu C, Zhang H, Zhang J, Xie C, Fan C, Zhang H, et al. Inflammation and Fibrosis in Perirenal Adipose Tissue of Patients With Aldosterone-Producing Adenoma. Endocrinology. 2018;159:227\u201337.","journal-title":"Endocrinology"},{"key":"2672_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/hr.2015.129","volume":"39","author":"S Karashima","year":"2016","unstructured":"Karashima S, Yoneda T, Kometani M, Ohe M, Mori S, Sawamura T, et al. Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism. Hypertens Res. 2016;39:133\u20137.","journal-title":"Hypertens Res"},{"key":"2672_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1507\/endocrj.EJ23-0103","volume":"71","author":"Y Takeda","year":"2024","unstructured":"Takeda Y, Demura M, Kometani M, Karashima S, Aono D, Konishi S, et al. Epigenetic alterations of 11beta-hydroxysteroid dehydrogenase 1 gene in the adipose tissue of patients with primary aldosteronism. Endocr J. 2024;71:245\u201352.","journal-title":"Endocr J"},{"key":"2672_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","volume":"94","author":"R Mullur","year":"2014","unstructured":"Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94:355\u201382.","journal-title":"Physiol Rev"},{"key":"2672_CR33","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1530\/EJE-21-0553","volume":"185","author":"M Swarbrick","year":"2021","unstructured":"Swarbrick M, Zhou H, Seibel M. MECHANISMS IN ENDOCRINOLOGY: Local and systemic effects of glucocorticoids on metabolism: new lessons from animal models. Eur J Endocrinol. 2021;185:R113\u2013r29.","journal-title":"Eur J Endocrinol"},{"key":"2672_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/bs.vh.2018.03.002","volume":"108","author":"K Sato","year":"2018","unstructured":"Sato K, Iemitsu M. The Role of Dehydroepiandrosterone (DHEA) in Skeletal Muscle. Vitam Horm. 2018;108:205\u201321.","journal-title":"Vitam Horm"},{"key":"2672_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00211","volume":"39","author":"RL Smith","year":"2018","unstructured":"Smith RL, Soeters MR, W\u00fcst RCI, Houtkooper RH. Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease. Endocr Rev. 2018;39:489\u2013517.","journal-title":"Endocr Rev"},{"key":"2672_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415\u201345.","journal-title":"Annu Rev Immunol"},{"key":"2672_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00211","volume":"39","author":"RL Smith","year":"2018","unstructured":"Smith RL, Soeters MR, W\u00fcst RC, Houtkooper RH. Metabolic flexibility as an adaptation to energy resources and requirements in health and disease. Endocr Rev. 2018;39:489\u2013517.","journal-title":"Endocr Rev"},{"key":"2672_CR38","doi-asserted-by":"crossref","unstructured":"Ekman N, Grossman AB, Nieckarz A, J\u0119drzejewski \u0141, Wolf J, Dworakowska D Non-Hypertensive Effects of Aldosterone. Int J Mol Sci. 2025;26:540.","DOI":"10.3390\/ijms26020540"},{"key":"2672_CR39","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.cmet.2017.04.015","volume":"25","author":"BH Goodpaster","year":"2017","unstructured":"Goodpaster BH, Sparks LM. Metabolic flexibility in health and disease. Cell Metab. 2017;25:1027\u201336.","journal-title":"Cell Metab"},{"key":"2672_CR40","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1055\/a-1547-9008","volume":"130","author":"E G\u00fcndo\u011fdu","year":"2022","unstructured":"G\u00fcndo\u011fdu E, Emekli E. CT-based Abdominal Adipose Tissue Area Changes in Patients Undergoing Adrenalectomy Due to Cushing\u2019s Syndrome and Non-functioning Adenomas. Exp Clin Endocrinol Diab. 2022;130:368\u201373.","journal-title":"Exp Clin Endocrinol Diab"},{"key":"2672_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","volume":"69","author":"M Naruse","year":"2022","unstructured":"Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69:327\u201359.","journal-title":"Endocr J"},{"key":"2672_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.997773","volume":"9","author":"H Xiang","year":"2022","unstructured":"Xiang H, Tao X, Guan X, Yin T, Li J, Dong D, et al. Contemporary Chinese dietary pattern: Where are the hidden risks? Front Nutr. 2022;9:997773.","journal-title":"Front Nutr"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02672-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02672-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02672-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:02:24Z","timestamp":1783296144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02672-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2672"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02672-y","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All study procedures and protocols were approved by the Ethics Committee of Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine. This study was registered at the Chinese Clinical Trial Registry (ChiCTR) under registration number ChiCTR2300070845 (\n                      \n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}